Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

01 January 2008

High throughput LC-MS/MS method for quantitative analysis of immunosuppressant drugs in whole blood using a triple quadrupole LC-MS/MS with an APCI source and implemented on column multiplexing LC system

R. Ruzicka, M. Kozak, V. Bodepudi, R. Loor, J. Zonderman

Ann Transplant 2008; 13(1): 36-36 :: ID: 880194

Abstract

Background: Our objective was to develop a high throughput, robust and simple method for quantification of any combination of immunosuppressants like sirolimus, tacrolimus, everolimus, and cyclosporin A by implementing APCI source and LC column multiplexing system.
Material/Methods: Blood samples were processed with a protein precipitation method and analyzed on 10-2.1 mm Hypersil C18 guard column with 2 min LC gradient method (1 min data collection time with two column switch method). Data was collected in MRM mode where ammoniated adducts of protonated molecules were used as precursor ions for all analytes. Ascomycin and cyclosporin D were used as internal standards. The whole blood calibrators and QC samples with concentrations across calibration range were prepared in house. The method was validated by processing and analyzing QC samples to obtain inter- and intra- assay variability. An interference study along with BioRad QC analysis was conducted to test method robustness. Extracted sample stability in autosampler rack at 8°C was obtained. Method was correlated with immunoassay by analyzing clinical samples.
Results: The quantification was performed with LOQ of 1 ng/mL and a linearity range 1-50 ng/mL for tacrolimus, sirolimus, everolimus and LOQ of 10 ng/mL and a linearity range of 10-2000 ng/mL for cyclosporin A. Intra and inter-assay CV's were all less than 10%. BioRad QC's results met supplier specification. No interferences were detected. Extracted samples were stable in 8°C for at least 24 hours.
Conclusions: Validation data demonstrates high throughput, robust method with a linearity range, accuracy and precision meeting industry standards.

Keywords: immunosuppressants, Everolimus, cyclosporin

Add Comment 0 Comments

In Press

Original article  

Prevalence and Risk Factors of Hepatic Steatosis in Kidney Transplant Recipients

Ann Transplant In Press; DOI: 10.12659/AOT.952251  

Original article  

The Anatomical Landscape of Living Donor Livers: A 101-Case Retrospective Single-Center Study in Indonesia ...

Ann Transplant In Press; DOI: 10.12659/AOT.952031  

Original article  

Decreased Ventilation Duration and ICU Stay Associated With Early Percutaneous Dilatational Tracheostomy Af...

Ann Transplant In Press; DOI: 10.12659/AOT.953143  

Original article  

Immunosuppression Withdrawal in Pediatric Liver Transplant Recipients with Posttransplant Lymphoproliferati...

Ann Transplant In Press; DOI: 10.12659/AOT.952021  

Most Viewed Current Articles

24 Aug 2021 : Review article   20,783

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

29 Dec 2021 : Original article   16,907

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

05 Apr 2022 : Original article   16,034

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   15,984

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358